CHOP vs R-CHOP in DLBCL 60-80 years. Event-free survival: 4-year update ... Rituximab plus CHOP is now internationally accepted as the standard first line ...
... disease Myeloid vs Lymphoid Based on the primary cell line involved Leukemias Lymphoid CLL ALL Myeloid CML AML Chronic Lymphocytic Leukemia CLL ...
Caroline Cr put R animation M dicale H pital Saint-Louis 23 F vrier 2005 D finition et Historique Hemophagocytose et histiocytes Fonctions macrophagiques ...
TATA. TSTA: unique to a tumor. Play an important role in tumor rejection. TATA: shared by normal and tumor cells. Tumor-associated developmental Ag (TADA) ...
Avanc es th rapeutiques 2004 : bilan des r alisations des entreprises du m dicament Introduction Pierre Le Sourd Pr sident du Leem Bilan des avanc es ...
HOW TO BUILD A PROSPECTIVE THERAPEUTIC TRIAL. Lo c Guillevin ... No. of bolus. 5.9 6.1. 5 1.5. 5.4 4.6. Time to reach CS 20 mg/d, (months) 10.6 3.6 ...
De nouveaux produits (18) dans de nombreuses pathologies et en particulier ... ont donc fait l'objet d'expertises approfondies. pour l'octroi d'une Autorisation de Mise ...